221 related articles for article (PubMed ID: 27987578)
21. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
[TBL] [Abstract][Full Text] [Related]
22. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
23. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
[TBL] [Abstract][Full Text] [Related]
24. [Postoperative three-dimensional conformal radiotherapy for resected non-small cell lung cancer].
Ji W; Wang LH; Ou GF; Liang J; Feng QF; Xiao ZF; Chen DF; Lü JM; Zhou ZM; Zhang HX; Yin WB
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):783-6. PubMed ID: 19173815
[TBL] [Abstract][Full Text] [Related]
25. Margin and local recurrence after sublobar resection of non-small cell lung cancer.
El-Sherif A; Fernando HC; Santos R; Pettiford B; Luketich JD; Close JM; Landreneau RJ
Ann Surg Oncol; 2007 Aug; 14(8):2400-5. PubMed ID: 17505859
[TBL] [Abstract][Full Text] [Related]
26. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
[TBL] [Abstract][Full Text] [Related]
27. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
[TBL] [Abstract][Full Text] [Related]
28. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
Koo HK; Jin SM; Lee CH; Lim HJ; Yim JJ; Kim YT; Yang SC; Yoo CG; Han SK; Kim JH; Shim YS; Kim YW
Lung Cancer; 2011 Aug; 73(2):222-9. PubMed ID: 21168237
[TBL] [Abstract][Full Text] [Related]
30. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
[TBL] [Abstract][Full Text] [Related]
31. Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer.
Brown LM; Louie BE; Jackson N; Farivar AS; Aye RW; Vallières E
Ann Thorac Surg; 2016 Oct; 102(4):1110-8. PubMed ID: 27350237
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
33. Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC.
Husain ZA; Kim AW; Yu JB; Decker RH; Corso CD
Clin Lung Cancer; 2015 Nov; 16(6):e183-7. PubMed ID: 25979646
[TBL] [Abstract][Full Text] [Related]
34. Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer.
Ambrogi MC; Fanucchi O; Dini P; Melfi F; Davini F; Lucchi M; Massimetti G; Mussi A
Eur Respir J; 2015 Apr; 45(4):1089-97. PubMed ID: 25700387
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of third-line and fourth-line chemotherapy for advanced non-small-cell lung cancer.
Asahina H; Sekine I; Horinouchi H; Nokihara H; Yamamoto N; Kubota K; Tamura T
Clin Lung Cancer; 2012 Jan; 13(1):39-43. PubMed ID: 21890422
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in non-small cell lung cancer patients with postoperative recurrence following third-generation chemotherapy.
Yamazaki K; Sugio K; Yamanaka T; Hirai F; Osoegawa A; Tagawa T; Fukuyama S; Wataya H; Seto T; Ichinose Y
Anticancer Res; 2010 Apr; 30(4):1311-5. PubMed ID: 20530445
[TBL] [Abstract][Full Text] [Related]
38. Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival.
Pirro M; Cagini L; Paciullo F; Pecoriello R; Mannarino MR; Bagaglia F; Capozzi R; Puma F; Mannarino E
Eur J Cardiothorac Surg; 2013 Oct; 44(4):e245-52. PubMed ID: 23882070
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
40. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
